Pharmacogenetic challenges for the health care system

John A. Robertson, Baruch Brody, Allen Buchanan, Jeffrey Kahn, Elizabeth McPherson

Research output: Contribution to journalArticlepeer-review

54 Scopus citations

Abstract

Pharmacogenetics-the effect of genotype on drug response-holds the promise of safer and more effective drug therapy. Genetic tests would be routinely given to patients prior to prescription of a drug, with therapeutic decisions based on the patient's drug-response profile. This paper examines the operational changes and the ethical, legal, and policy challenges that pharmacogenetic medicine poses for key actors in the health care system. Adaptation by drug companies, regulatory agencies, physicians, patients, insurers, and public funding agencies will be necessary to integrate pharmacogenetic medicine into health care.

Original languageEnglish (US)
Pages (from-to)155-167
Number of pages13
JournalHealth Affairs
Volume21
Issue number4
DOIs
StatePublished - 2002

ASJC Scopus subject areas

  • Health Policy

Fingerprint

Dive into the research topics of 'Pharmacogenetic challenges for the health care system'. Together they form a unique fingerprint.

Cite this